首页> 外文期刊>Molecular therapy: the journal of the American Society of Gene Therapy >Generation of transgenic mice using lentiviral vectors: a novel preclinical assessment of lentiviral vectors for gene therapy.
【24h】

Generation of transgenic mice using lentiviral vectors: a novel preclinical assessment of lentiviral vectors for gene therapy.

机译:使用慢病毒载体产生转基因小鼠:用于基因治疗的慢病毒载体的新型临床前评估。

获取原文
获取原文并翻译 | 示例
       

摘要

Lentiviral vectors have become attractive delivery vehicles for gene therapy investigators. Specifically, the ability of lentiviral vectors to integrate into nondividing cells and provide stable and long-term gene expression in vivo is a desirable attribute of gene therapy approaches. We report here a simple method for generating transgenic mice using lentiviral vectors, which could be useful models for gene therapy. After removal of the zona pellucida, fertilized eggs were co-incubated with oncoretroviral or lentiviral vectors. The resulting blastocysts were transferred into uteri of pseudo-pregnant females. In both cases, around 60-70% of founder pups were transgenic as determined by PCR analysis. Southern blot analysis revealed that the transgenes were integrated at different genetic loci and transmitted through the germ line. Most of the transgenes delivered by lentiviral vectors were expressed in transgenic mice, although those delivered by oncoretroviral vectors were completely silenced. When theupstream sequences of the rhodopsin gene and the red pigment gene were used as tissue-specific promoters, consistent enhanced green fluorescent protein (EGFP) expression was observed in rod and cone photoreceptor cells, respectively, in retina. However, mice generated with the corneal epithelium-specific keratin-12 promoter displayed EGFP expression not only in cornea but also in other tissues of the mouse. We conclude that the generation of transgenic mice using lentiviral vectors is a simple and robust method to evaluate the promoter specificity in lentiviral vectors in vivo prior to undertaking a gene therapy strategy.
机译:慢病毒载体已成为基因治疗研究人员的有吸引力的运载工具。具体地说,慢病毒载体整合入非分裂细胞并在体内提供稳定和长期基因表达的能力是基因治疗方法的理想属性。我们在这里报告了一种使用慢病毒载体产生转基因小鼠的简单方法,这可能是基因治疗的有用模型。去除透明带后,将受精卵与轮状病毒或慢病毒载体共孵育。由此产生的胚泡被转移到假孕女性的子宫中。在两种情况下,通过PCR分析确定,约有60-70%的创始人幼犬是转基因的。 Southern印迹分析显示转基因整合在不同的基因座上并通过种系传播。慢病毒载体传递的大多数转基因都在转基因小鼠中表达,尽管核心病毒载体传递的那些已被完全沉默。当视紫红质基因和红色色素基因的上游序列用作组织特异性启动子时,分别在视网膜的视杆和视锥细胞中观察到一致的增强的绿色荧光蛋白(EGFP)表达。但是,用角膜上皮特异性角蛋白12启动子生成的小鼠不仅在角膜中而且在小鼠的其他组织中均显示EGFP表达。我们得出的结论是,使用慢病毒载体产生转基因小鼠是一种简单而健壮的方法,可在进行基因治疗策略之前评估体内慢病毒载体中的启动子特异性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号